Johnson & Johnson Settles $2.2 Billion Pharma Fraud Case

In November, drug giant Johnson & Johnson (J&J) and its subsidiaries agreed to pay $2.2 billion in fines and fees for wrongdoing related to kickbacks and misbranding of a number of their medications.

Current Subscribers

Purchase a subscription

To view the full content, you need to purchase a subscription.